Insider Trading activities of Achillion Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Achillion Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Achillion Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Achillion Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is ACHN. The reporting company's CIK number is 1070336.
The total value of stock buying since 2005 is $79,854,393.
The total value of stock sales since 2005 is $13,531,823,027.
The total value of stock option exercises since 2005 is $15,115,056.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Achillion Pharmaceuticals Inc (ACHN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-08 0 $0 0 $0 2,811,245 $8,751,405
2016-12 10,000 $39,600 0 $0 0 $0
2015-12 0 $0 53,500 $543,480 53,500 $75,875
2015-11 0 $0 550,000 $5,595,710 0 $0
2015-09 0 $0 9,310 $76,528 0 $0
2015-08 0 $0 37,843 $284,200 0 $0
2015-01 0 $0 113,125 $1,710,000 113,125 $354,500
2014-09 0 $0 8,267,169 $13,364,194,170 0 $0
2014-08 0 $0 8,261,274 $85,156,815 742,436 $2,730,084
2014-06 0 $0 3,330,137 $26,249,637 501,937 $1,350,739
2013-12 0 $0 896,000 $2,903,519 0 $0
2013-11 2,930,000 $7,369,160 0 $0 0 $0
2013-10 6,003,946 $15,685,348 0 $0 0 $0
2013-09 5,009,657 $16,613,296 3,361,502 $13,833,219 0 $0
2013-08 596,134 $3,897,234 37,363 $262,276 0 $0
2013-07 3,554,545 $22,690,900 110,060 $795,826 5,000 $13,300
2013-06 40,000 $313,100 5,000 $41,849 5,000 $13,300
2013-01 0 $0 26,965 $226,613 26,965 $86,018
2012-12 0 $0 88,168 $706,049 88,168 $182,948
2012-09 0 $0 18,255 $160,050 18,255 $60,764
2012-06 20,000 $123,890 26,250 $164,791 26,250 $43,662
2012-05 0 $0 1,316,956 $9,867,951 0 $0
2012-03 0 $0 10,108 $108,242 10,108 $15,245
2012-01 0 $0 361,253 $4,205,417 356,878 $867,582
2011-12 0 $0 12,501 $94,681 12,501 $43,600
2011-11 5,000 $29,785 0 $0 0 $0
2011-09 0 $0 15,219 $91,017 15,219 $15,979
2011-08 10,000 $53,940 0 $0 0 $0
2011-07 0 $0 1,115 $8,652 0 $0
2011-06 0 $0 179,944 $1,399,787 164,319 $308,558
2011-05 0 $0 47,800 $335,269 47,800 $50,190
2011-04 0 $0 15,250 $104,518 11,000 $23,760
2011-03 0 $0 436,348 $2,598,899 7,726 $8,112
2011-02 0 $0 156,787 $795,727 0 $0
2011-01 0 $0 23,062 $113,277 14,312 $26,935
2010-10 0 $0 0 $0 25,000 $75,500
2010-08 4,875,502 $12,139,999 0 $0 0 $0
2010-07 10,000 $23,929 0 $0 0 $0
2010-04 10,000 $30,230 0 $0 0 $0
2010-01 0 $0 286,990 $1,067,088 0 $0
2009-12 0 $0 2,381,926 $8,109,617 0 $0
2009-09 10,000 $19,514 0 $0 0 $0
2008-12 795,000 $784,537 0 $0 0 $0
2008-11 24,700 $24,700 0 $0 0 $0
2008-09 4,654 $10,481 0 $0 3,125 $5,000
2008-08 2,000 $4,750 0 $0 0 $0
2007-04 0 $0 3,125 $18,153 3,125 $5,000
2006-12 0 $0 0 $0 4,375 $7,000

Table 2. Detailed insider stock purchases, sales, and option exercises of Achillion Pharmaceuticals Inc insiders (ACHN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-08-10 Vitullo Nicole (Director) Option Ex 2,811,245 3.11 8,751,405
2016-12-22 Fisherman Jason S (Director) Buy 10,000 3.96 39,600
2015-12-30 Apelian David (Chief Medical Officer) Sale 10,000 10.50 105,000
2015-12-30 Apelian David (Chief Medical Officer) Option Ex 10,000 3.02 30,200
2015-12-28 Fenton Mary Kay (Chief Financial Officer) Sale 43,500 10.08 438,480
2015-12-28 Fenton Mary Kay (Chief Financial Officer) Option Ex 43,500 1.05 45,675
2015-11-11 Vitullo Nicole (Director) Sale 50,000 10.31 515,500
2015-11-10 Vitullo Nicole (Director) Sale 179,074 10.43 1,867,741
2015-11-09 Vitullo Nicole (Director) Sale 320,926 10.01 3,212,469
2015-09-25 Vitullo Nicole (Director) Sale 9,310 8.22 76,528
2015-08-14 Vitullo Nicole (Director) Sale 37,843 7.51 284,200
2015-01-23 Fenton Mary Kay (EVP and CFO) Sale 13,125 16.00 210,000
2015-01-23 Fenton Mary Kay (EVP and CFO) Option Ex 13,125 4.00 52,500
2015-01-21 Deshpande Milind (President and CEO) Sale 100,000 15.00 1,500,000
2015-01-21 Deshpande Milind (President and CEO) Option Ex 100,000 3.02 302,000
2014-09-30 Ra Capital Healthcare Fund Lp Sale 1,111,000 10.06 11,176,660
2014-09-29 Ra Capital Healthcare Fund Lp Sale 221,014 10.96 2,423,197
2014-09-26 Ra Capital Healthcare Fund Lp Sale 670,000 11.06 7,408,190
2014-09-25 Ra Capital Healthcare Fund Lp Sale 497,986 11.04 5,499,259
2014-09-24 Ra Capital Healthcare Fund Lp Sale 1,204,929 11.26 13,571,115
2014-09-23 Ra Capital Healthcare Fund Lp Sale 984,522 11.08 10,905,550
2014-09-22 Ra Capital Healthcare Fund Lp Sale 445,689 11.09 4,941,799
2014-09-19 Ra Capital Healthcare Fund Lp Sale 1,164,860 11.67 13,589,256
2014-09-11 Kolchinsky Peter Sale 1,181,912 12.39 14,646,253
2014-09-10 Kolchinsky Peter Sale 522,450 25,412.73 13,276,881,310
2014-09-02 Kolchinsky Peter Sale 262,807 11.99 3,151,581
2014-08-29 Kolchinsky Peter Sale 398,845 11.44 4,561,191
2014-08-28 Kolchinsky Peter Sale 173,641 11.51 1,999,302
2014-08-27 Kolchinsky Peter Sale 267,089 11.61 3,101,170
2014-08-26 Kolchinsky Peter Sale 2,112,867 11.53 24,352,905
2014-08-25 Truitt Joseph (EVP, Chief Commercial Officer) Sale 25,000 10.82 270,500
2014-08-25 Truitt Joseph (EVP, Chief Commercial Officer) Option Ex 25,000 .82 20,500
2014-08-25 Kolchinsky Peter Sale 331,396 10.97 3,636,739
2014-08-18 Deshpande Milind (President and CEO) Sale 216,624 10.00 2,166,240
2014-08-18 Deshpande Milind (President and CEO) Option Ex 216,624 2.86 619,111
2014-08-18 Ra Capital Healthcare Fund Lp Sale 1,993,978 9.66 19,255,845
2014-08-15 Ra Capital Healthcare Fund Lp Sale 2,241,022 9.41 21,083,534
2014-08-15 Kishbauch Michael D (Director) Sale 495,812 9.46 4,689,389
2014-08-15 Kishbauch Michael D (Director) Option Ex 495,812 4.18 2,074,973
2014-08-13 Frashier Gary E (Director) Sale 5,000 8.00 40,000
2014-08-13 Frashier Gary E (Director) Option Ex 5,000 3.10 15,500
2014-06-20 Ra Capital Management, Llc Sale 880,000 8.35 7,349,760
2014-06-16 Truitt Joseph (EVP, Chief Commercial Officer) Sale 25,000 7.82 195,500
2014-06-16 Truitt Joseph (EVP, Chief Commercial Officer) Option Ex 25,000 .82 20,500
2014-06-16 Qvt Associates Gp Llc (10% Owner) Sale 1,819,551 7.75 14,094,242
2014-06-16 Frashier Gary E (Director) Sale 55,000 8.00 440,000
2014-06-16 Frashier Gary E (Director) Option Ex 55,000 2.48 136,235
2014-06-11 Qvt Associates Gp Llc (10% Owner) Sale 87,024 7.64 664,863
2014-06-10 Truitt Joseph (EVP, Chief Commercial Officer) Sale 48,950 6.05 296,147
2014-06-10 Truitt Joseph (EVP, Chief Commercial Officer) Option Ex 48,950 .82 40,139
2014-06-10 Qvt Associates Gp Llc (10% Owner) Sale 41,625 7.72 321,553
2014-06-10 Kishbauch Michael D (Director) Sale 371,937 7.75 2,882,511
2014-06-10 Kishbauch Michael D (Director) Option Ex 371,937 3.10 1,153,004
2014-06-09 Truitt Joseph (EVP, Chief Commercial Officer) Sale 1,050 4.82 5,061
2014-06-09 Truitt Joseph (EVP, Chief Commercial Officer) Option Ex 1,050 .82 861
2013-12-30 Qvt Associates Gp Llc (10% Owner) Sale 80,439 3.30 265,448
2013-12-27 Qvt Associates Gp Llc (10% Owner) Sale 89,800 3.38 303,973
2013-12-26 Qvt Associates Gp Llc (10% Owner) Sale 80,992 3.44 278,207
2013-12-24 Qvt Associates Gp Llc (10% Owner) Sale 40,213 3.43 137,930
2013-12-23 Qvt Associates Gp Llc (10% Owner) Sale 181,986 3.31 601,827
2013-12-20 Qvt Associates Gp Llc (10% Owner) Sale 107,155 3.16 338,609
2013-12-19 Qvt Associates Gp Llc (10% Owner) Sale 132,800 3.12 414,336
2013-12-18 Qvt Associates Gp Llc (10% Owner) Sale 89,812 3.06 274,824
2013-12-17 Qvt Associates Gp Llc (10% Owner) Sale 42,156 3.08 129,840
2013-12-16 Qvt Associates Gp Llc (10% Owner) Sale 50,647 3.13 158,525
2013-11-22 Liotta Dennis (Director) Buy 10,000 2.98 29,800
2013-11-20 Ra Capital Healthcare Fund Lp Buy 1,110,000 2.57 2,848,260
2013-11-19 Fisherman Jason S (Director) Buy 5,000 2.56 12,800
2013-11-18 Fisherman Jason S (Director) Buy 10,000 2.67 26,700
2013-11-12 Ra Capital Management, Llc Buy 1,795,000 2.48 4,451,600
2013-10-31 Ra Capital Healthcare Fund Lp Buy 1,186,007 2.38 2,823,882
2013-10-14 Ra Capital Healthcare Fund Lp Buy 2,369,229 2.79 6,617,256
2013-10-11 Ra Capital Healthcare Fund Lp Buy 2,448,710 2.55 6,244,210
2013-09-30 Qvt Fund V Lp (10% Owner) Sale 2,754,900 3.40 9,366,660
2013-09-30 Kolchinsky Peter Buy 1,552,000 3.50 5,432,000
2013-09-30 Ra Capital Healthcare Fund Lp Buy 2,800,000 2.99 8,366,400
2013-09-27 Kolchinsky Peter Buy 600,000 4.00 2,400,000
2013-09-25 Kolchinsky Peter Sale 135,800 7.26 985,908
2013-09-24 Kolchinsky Peter Sale 181,429 7.34 1,331,507
2013-09-23 Kolchinsky Peter Sale 33,448 7.42 248,083
2013-09-20 Kolchinsky Peter Sale 26,539 7.40 196,494
2013-09-18 Kolchinsky Peter Sale 2,328 7.48 17,413
2013-09-17 Kolchinsky Peter Sale 77,600 7.42 576,024
2013-09-16 Kolchinsky Peter Sale 91,801 7.53 690,894
2013-09-12 Kolchinsky Peter Buy 18,857 7.20 135,808
2013-09-12 Kolchinsky Peter Sale 18,857 7.26 136,996
2013-09-11 Kolchinsky Peter Buy 38,800 7.19 279,088
2013-09-11 Kolchinsky Peter Sale 38,800 7.30 283,240
2013-08-28 Kolchinsky Peter Buy 38,500 6.38 245,822
2013-08-27 Kolchinsky Peter Buy 77,000 6.49 499,345
2013-08-26 Kolchinsky Peter Buy 154,000 6.58 1,013,012
2013-08-22 Kolchinsky Peter Buy 52,652 6.76 356,190
2013-08-21 Kolchinsky Peter Buy 23,100 6.69 154,585
2013-08-21 Kolchinsky Peter Sale 4,312 6.87 29,640
2013-08-20 Kolchinsky Peter Buy 38,500 6.75 259,836
2013-08-20 Kolchinsky Peter Sale 9,951 6.86 68,303
2013-08-14 Fisherman Jason S (Director) Buy 5,000 6.83 34,150
2013-08-12 Liotta Dennis (Director) Buy 5,000 6.47 32,335
2013-08-09 Qvt Fund V Lp (10% Owner) Buy 65,982 6.37 420,305
2013-08-09 Kolchinsky Peter Buy 77,000 6.30 485,100
2013-08-08 Qvt Fund V Lp (10% Owner) Buy 36,300 6.48 235,224
2013-08-05 Kolchinsky Peter Sale 23,100 7.11 164,333
2013-08-02 Kolchinsky Peter Buy 23,100 6.98 161,330
2013-07-29 Kolchinsky Peter Buy 17,894 6.90 123,522
2013-07-29 Kolchinsky Peter Sale 3,377 6.95 23,480
2013-07-25 Kolchinsky Peter Buy 37,250 7.20 268,013
2013-07-25 Kolchinsky Peter Sale 55,421 7.17 397,479
2013-07-24 Kolchinsky Peter Sale 7,862 7.25 57,038
2013-07-22 Kolchinsky Peter Buy 63,283 7.20 455,384
2013-07-19 Kolchinsky Peter Sale 38,400 7.21 276,979
2013-07-17 Kolchinsky Peter Buy 38,400 7.09 272,371
2013-07-11 Qvt Fund V Lp (10% Owner) Buy 401,017 6.46 2,592,574
2013-07-10 Qvt Fund V Lp (10% Owner) Buy 190,944 6.37 1,215,358
2013-07-09 Qvt Fund V Lp (10% Owner) Buy 200,000 6.30 1,260,000
2013-07-08 Qvt Fund V Lp (10% Owner) Buy 445,209 6.30 2,804,816
2013-07-05 Qvt Fund V Lp (10% Owner) Buy 197,300 6.24 1,230,165
2013-07-03 Qvt Fund V Lp (10% Owner) Buy 463,248 6.28 2,909,197
2013-07-02 Qvt Fund V Lp (10% Owner) Buy 1,500,000 6.37 9,559,500
2013-07-01 Frashier Gary E (Director) Sale 5,000 8.17 40,850
2013-07-01 Frashier Gary E (Director) Option Ex 5,000 2.66 13,300
2013-06-21 Fisherman Jason S (Director) Buy 10,000 7.63 76,300
2013-06-07 Frashier Gary E (Director) Sale 5,000 8.37 41,849
2013-06-07 Frashier Gary E (Director) Option Ex 5,000 2.66 13,300
2013-06-03 Liotta Dennis (Director) Buy 20,000 7.91 158,100
2013-06-03 Fisherman Jason S (Director) Buy 10,000 7.87 78,700
2013-01-02 Shah Gautam (EVP and Chief Compliance Ofc.) Sale 26,965 8.40 226,613
2013-01-02 Shah Gautam (EVP and Chief Compliance Ofc.) Option Ex 26,965 3.19 86,018
2012-12-31 Shah Gautam (EVP and Chief Compliance Ofc.) Sale 88,168 8.01 706,049
2012-12-31 Shah Gautam (EVP and Chief Compliance Ofc.) Option Ex 88,168 2.08 182,948
2012-09-27 Shah Gautam (EVP and Chief Compliance Ofc.) Sale 7,005 10.00 70,050
2012-09-27 Shah Gautam (EVP and Chief Compliance Ofc.) Option Ex 7,005 4.82 33,764
2012-09-12 Shah Gautam (EVP and Chief Compliance Ofc.) Sale 11,250 8.00 90,000
2012-09-12 Shah Gautam (EVP and Chief Compliance Ofc.) Option Ex 11,250 2.40 27,000
2012-06-15 Wright David P (Director) Sale 10,000 6.43 64,269
2012-06-15 Wright David P (Director) Option Ex 10,000 2.66 26,600
2012-06-12 Liotta Dennis (Director) Buy 10,000 6.16 61,550
2012-06-11 Liotta Dennis (Director) Buy 10,000 6.23 62,340
2012-06-11 Frashier Gary E (Director) Sale 16,250 6.19 100,522
2012-06-11 Frashier Gary E (Director) Option Ex 16,250 1.05 17,062
2012-05-31 Steinmetz Michael (10% Owner) Sale 1,316,956 7.49 9,867,951
2012-03-19 Shah Gautam (SVP and Chief Compliance Ofc.) Sale 2,078 10.52 21,860
2012-03-19 Shah Gautam (SVP and Chief Compliance Ofc.) Option Ex 2,078 3.28 6,815
2012-03-16 Shah Gautam (SVP and Chief Compliance Ofc.) Sale 2,718 10.87 29,544
2012-03-16 Shah Gautam (SVP and Chief Compliance Ofc.) Option Ex 2,718 1.05 2,853
2012-03-15 Deshpande Milind (President and CSO) Sale 5,312 10.70 56,838
2012-03-15 Deshpande Milind (President and CSO) Option Ex 5,312 1.05 5,577
2012-01-13 Kishbauch Michael D (CEO and President) Sale 198,306 12.63 2,505,398
2012-01-13 Kishbauch Michael D (CEO and President) Option Ex 198,306 2.80 555,256
2012-01-11 Kishbauch Michael D (CEO and President) Sale 8,900 12.50 111,267
2012-01-11 Kishbauch Michael D (CEO and President) Option Ex 8,900 1.60 14,240
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of ACHN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Achillion Pharmaceuticals Inc (symbol ACHN, CIK number 1070336) see the Securities and Exchange Commission (SEC) website.